Ureteral Obstruction Market Research Report By Product Type (Ureteral Stents, Ureteral Catheters, Balloon Dilators, Nephrostomy Tubes, Others), By End-user (Hospitals, Ambulatory Surgical Centers, Specialty Clinics), By Indication (Calculi, Tumors, Congenital Ureteral Obstructions, Inflammatory Strictures), By Material (Metallic, Silicone, Polymeric, Biodegradable), and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)-Forecast to 2035

Global Ureteral Obstruction Market Overview

As per MRFR analysis, the Ureteral Obstruction Market Size was estimated at 1.16 (USD Billion) in 2023. The Ureteral Obstruction Market is expected to grow from 1.24 (USD Billion) in 2024 to 2.5 (USD Billion) by 2035. The Ureteral Obstruction Market CAGR (growth rate) is expected to be around 6.58% during the forecast period (2025 - 2035).

Key Ureteral Obstruction Market Trends Highlighted

There are certain noteworthy trends that are currently reshaping the global ureteric obstruction market. The rising incidence of urinary tract illnesses, which has increased need for efficient treatment alternatives, is one of the major factors propelling the market. Additionally, the market is growing since the world's aging population is increasingly vulnerable to illnesses that cause ureteral blockage.

Another noteworthy development is the move toward less intrusive surgical methods, which are associated with fewer problems and faster recovery periods than standard surgery. A rising preference for patient-centered treatment techniques is demonstrated by the rise in the use of ureteroscopy and endourology procedures.

This industry has a lot of untapped potential, especially in developing nations where healthcare infrastructure is still in its infancy. Growing healthcare costs and better medical facilities offer the chance to implement cutting-edge, locally specific treatment options.

Advanced ureteral stents and associated devices may find it easier to enter these markets through partnerships and collaborations between domestic and foreign medical device firms. In order to reduce problems and improve patient compliance, biocompatible materials for ureteral stents have been developed more recently.

Because they promise improved clinical results, stent design innovations that address problems like encrustation and migration are being given priority.

Telemedicine and remote monitoring technologies, which can improve patient management and follow-up treatment for individuals with ureteral blockages, are also becoming more prevalent in the business. The future of the global ureteric obstruction market is probably going to be shaped by this confluence of possibilities and technical developments.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Ureteral Obstruction Market Drivers

Rising Incidence of Ureteral Obstructions

The Ureteral Obstruction Market is significantly driven by the increasing incidence of ureteral obstructions, which are primarily caused by conditions such as kidney stones, tumors, and strictures.

According to the World Health Organization (WHO), the prevalence of kidney stones has increased substantially, with estimates suggesting that about 10% of men and 5% of women are expected to develop kidney stones at some point in their lives. This rise in kidney-related ailments contributes directly to the demand for ureteral obstruction treatments.

Additionally, established organizations like the National Institute of Health (NIH) emphasize the growing burden of ureteral blockages, indicating that approximately 1 in 8 hospitalizations related to renal issues are due to obstructive uropathy.

This increasing rate of conditions necessitating medical intervention fuels the demand for ureteral obstruction management solutions, thereby propelling the growth of the Ureteral Obstruction Market.

Technological Advancements in Medical Devices

Another prominent driver for the Ureteral Obstruction Market is the continuous technological advancements in medical devices used for diagnosing and treating ureteral obstructions. Innovations such as minimally invasive techniques and advanced imaging technologies have significantly improved patient outcomes.

The Food and Drug Administration (FDA) has recently approved several advanced ureteral stents and catheter systems that are designed to enhance the safety and effectiveness of procedures.

This approval boosts competition among device manufacturers, resulting in better quality products at competitive prices. The growing emphasis on patient safety and efficiency in healthcare settings further encourages the adoption of these modern devices, positively impacting the Ureteral Obstruction Market.

Aging Population and Related Health Issues

The aging population is a crucial driver for the Ureteral Obstruction Market, as older adults are more susceptible to diseases that can cause ureteral obstructions, such as prostate enlargement and kidney disorders.

The United Nations reports that the proportion of the global population aged 60 years and older is projected to double from 12% in 2015 to 22% by 2050. This demographic trend will inevitably lead to higher incidences of urinary tract issues, necessitating effective treatment options for ureteral obstructions.

Furthermore, healthcare providers recognize the urgent need to address these conditions among the aging populace, resulting in increased investments from healthcare systems and organizations to enhance treatment modalities in the Ureteral Obstruction Market.

Ureteral Obstruction Market Segment Insights

Ureteral Obstruction Market Product Type Insights

The Ureteral Obstruction Market, segmented by Product Type, reflected a diversified landscape with specific categories catering to various clinical needs.

In 2024, the valuation for Ureteral Stents stood at 0.45 USD Billion, and this is projected to grow to 0.94 USD Billion by 2035, indicating its dominant position in the market with majority holding. This product was critical as it directly addressed the management of ureteral obstructions, offering essential drainage and support for kidney function.

Ureteral Catheters, valued at 0.25 USD Billion in 2024 and expected to reach 0.52 USD Billion by 2035, also served a significant role in treatment protocols, facilitating the passage of urine from the kidneys to the bladder, thus underscoring their importance in urinary health.

Balloon Dilators represent another critical facet of the market with a valuation of 0.15 USD Billion in 2024, projected to increase to 0.32 USD Billion by 2035. These devices were pivotal during minimally invasive procedures to widen obstructed ureters, thus enhancing surgical options.

Nephrostomy Tubes, valued at 0.20 USD Billion in 2024 and anticipated to expand to 0.42 USD Billion by 2035, played a crucial role in patients suffering from severe urinary blockage, offering a direct pathway for urine elimination and contributing to patient comfort and care. The "Others" category, representing miscellaneous devices, is set to grow from 0.19 USD Billion in 2024 to 0.50 USD Billion in 2035.

Each product type within the Ureteral Obstruction Market not only showcases substantial individual growth trends but collectively enhances patient management across various healthcare environments.

The increasing prevalence of urinary tract disorders, coupled with advancements in medical technology, are significant growth drivers for these product types, addressing both treatment efficacy and patient safety.

Existing market dynamics indicate a need for continuous innovation and adaptation to effectively meet the demands of healthcare settings, thereby presenting ongoing opportunities for development within this global Market.

As healthcare systems worldwide continue to evolve, particularly towards minimally invasive techniques, these product types will remain integral to improving the quality of care in treating ureteral obstructions.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Ureteral Obstruction Market End-user Insights

The market is characterized by a diverse range of facilities, including Hospitals, Ambulatory Surgical Centers, and Specialty Clinics, each serving unique functions in patient care. Hospitals often play a pivotal role due to their comprehensive services and ability to accommodate complex cases.

Ambulatory Surgical Centers are gaining traction as they offer efficient outpatient services, catering to the rising demand for minimally invasive procedures. Specialty Clinics, focused on specific areas such as urology, are significant as they provide expert care and specialized treatments tailored to ureteral obstruction.

The growth of this market can be attributed to increasing incidences of urinary tract disorders, advancements in medical technology, and ongoing investment in healthcare infrastructure. However, challenges such as reimbursement issues and operational costs may impact market growth.

Overall, understanding the Ureteral Obstruction Market segmentation is crucial for stakeholders looking to navigate this evolving landscape effectively.

Ureteral Obstruction Market Indication Insights

The growth is driven by an increasing prevalence of ureteral obstructions due to various indications. Key indications include Calculi, which are among the most common causes, severely affecting patient health and treatment outcomes.

Tumors also pose a significant challenge, as they can lead to serious complications and require timely intervention. Additionally, Congenital Ureteral Obstructions represent a crucial area since early diagnosis can significantly improve patient prognosis.

Inflammatory Strictures are another important indication, often resulting from infections or previous surgeries, leading to increased healthcare costs. As the Ureteral Obstruction Market segmentation reveals, these indications are vital for understanding market dynamics and demand trends.

The market's growth is supported by advancements in surgical techniques and therapeutic agents, addressing these indications effectively. Overall, the importance of these indications cannot be understated, as they persistently dominate the landscape of ureteral obstruction treatments globally, influencing both clinical practices and research directions.

Ureteral Obstruction Market Material Insights

The Ureteral Obstruction Market, predominantly focusing on the Material segment. The market is poised for substantial growth due to rising incidences of ureteral obstructions which necessitate effective intervention.

The segmentation within this market includes a variety of materials such as Metallic, Silicone, Polymeric, and Biodegradable. Among these, Metallic components are often preferred for their durability and long-term performance, while Silicone materials are esteemed for their flexibility and biocompatibility, making them suitable for various applications.

Additionally, Polymeric materials play a crucial role due to their versatility and the ability to be tailored for specific medical needs. Meanwhile, Biodegradable materials are emerging as significant players, offering environmentally friendly solutions that also support patient health by reducing long-term complications associated with non-dissolvable products.

This diversification in materials reflects ongoing trends towards innovation and the development of patient-centric solutions within the Ureteral Obstruction Market, emphasizing the industry's dynamic growth trajectory.

Ureteral Obstruction Market Regional Insights

The Ureteral Obstruction Market saw a diverse range of revenue generation across its regional segments in the coming years. North America led with a market value of 0.62 USD Billion in 2024 and is projected to reach 1.23 USD Billion by 2035, highlighting its majority holding due to advanced healthcare infrastructure and high demand for medical solutions.

Europe followed, valued at 0.30 USD Billion in 2024 and expected to grow to 0.60 USD Billion by 2035, backed by an increase in awareness and availability of treatment options.

In South America, the market was valued at 0.10 USD Billion in 2024 and anticipated to grow to 0.20 USD Billion by 2035, showing signs of gradual improvement in healthcare accessibility and policy support. The Asia Pacific region, valued at 0.18 USD Billion in 2024, is projected to grow to 0.35 USD Billion by 2035, driven by a large population base and increasing investments in healthcare innovation.

Finally, the Middle East and Africa segment held a value of 0.04 USD Billion in 2024, with expectations of growing to 0.12 USD Billion by 2035, reflecting new opportunities arising from improving healthcare systems and increasing patient awareness.

These dynamics across the regional markets contributed significantly to the overall landscape of the Ureteral Obstruction Market revenue, with each region playing a critical role in driving growth and meeting patient needs in various contexts.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

Ureteral Obstruction Market Key Players and Competitive Insights

The Ureteral Obstruction Market is characterized by significant competitive dynamics, driven by various factors such as increasing incidences of ureteral obstructions due to kidney stones, tumors, and other urological conditions, along with a growing aging population.

The market comprises numerous players who focus on developing innovative products and solutions to enhance patient outcomes and improve procedural efficiencies. Companies in this space are leveraging advanced technologies and conducting rigorous clinical research to introduce effective medical devices, including stents and drainage systems.

The competitive landscape is continually evolving, influenced by strategic initiatives such as partnerships, collaborations, and mergers and acquisitions, aimed at broadening product offerings and enhancing market reach.

Coloplast has established a strong presence in the Ureteral Obstruction Market through its commitment to enhancing the quality of life for individuals suffering from urinary tract disorders. The company is recognized for its high-quality medical devices, particularly in developing innovative stent technologies and other urological products that address ureteral obstructions.

Coloplast's strengths lie in its research capabilities, which allow for the continuous improvement of their existing products while introducing new, state-of-the-art solutions. The company actively invests in product innovation and customer feedback, ensuring that their offerings meet the evolving needs of healthcare providers and patients.

Coloplast’s robust market presence is strengthened by its global distribution network, allowing it to effectively reach diverse healthcare markets while maintaining a strong reputation for reliability and quality.

Key Companies in the Ureteral Obstruction Market Include

• Coloplast


• Teleflex


• Stryker


• Cook Medical


• R. Bard


• Medtronic


• Karl Storz


• Baxter


• Johnson & Johnson


• Olympus Corporation


• Merit Medical Systems


• Boston Scientific

Ureteral Obstruction Market Developments

With its innovative floating coil design that minimizes bladder spasms and lowers reflux to zero in clinical imaging studies, the RELIEFTM ureteral stent was approved by the FDA on December 20, 2024, making it the first stent approved for preventing vesicoureteral reflux, according to University Hospitals Urology Institute.

On April 29, 2025, researchers from ETH Zurich, Inselspital, and the University of Bern presented a non-invasive ultrasound-activated artificial cilia technology that can clean ureteral stents through the skin in a matter of minutes, thereby eliminating biofilms and encrustations and possibly lowering the frequency of replacements.

The creation of 3D-printed biodegradable ureteral stents composed of PLA, Tough PLA, and PLA/PHB was described in an April 2025 paper published in MDPI. These stents showed promising biodegradation rates, mechanical integrity, and the ability to be customized for each patient.

Furthermore, on April 16, 2025, engineering research unveiled a ureteroscope with a spinner that can use spiral suction flow to capture more than 60 kidney stone particles every pass, greatly increasing the removal efficiency during retrograde intrarenal surgery.

Last but not least, on March 21, 2025, it was revealed that the NAVIUS augmented reality navigation system for ureteroscopic surgeries reduced the cognitive burden of the surgeon by more than 27% and improved scope coverage by about 24%, indicating significant improvements in procedural safety and accuracy.

Ureteral Obstruction Market Segmentation Insights

• Ureteral Obstruction Market Product Type Outlook
  
  
  
  • Ureteral Stents
  
  
  • Ureteral Catheters
  
  
  • Balloon Dilators
  
  
  • Nephrostomy Tubes
  
  
  • Others
  
  
  
  

• Ureteral Obstruction Market End-user Outlook
  
  
  
  • Hospitals
  
  
  • Ambulatory Surgical Centers
  
  
  • Specialty Clinics
  
  
  
  

• Ureteral Obstruction Market Indication Outlook
  
  
  
  • Calculi
  
  
  • Tumors
  
  
  • Congenital Ureteral Obstructions
  
  
  • Inflammatory Strictures
  
  
  
  

• Ureteral Obstruction Market Material Outlook
  
  
  
  • Metallic
  
  
  • Silicone
  
  
  • Polymeric
  
  
  • Biodegradable
  
  
  
  

• Ureteral Obstruction Market Regional Outlook
  
  
  
  • North America
  
  
  • Europe
  
  
  • South America
  
  
  • Asia Pacific
  
  
  • Middle East and Africa
  
  
  
  

Report Attribute/Metric	Details
Market Size 2023	1.16(USD Billion)
Market Size 2024	1.24(USD Billion)
Market Size 2035	2.5(USD Billion)
Compound Annual Growth Rate (CAGR)	6.58% (2025 - 2035)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2024
Market Forecast Period	2025 - 2035
Historical Data	2019 - 2024
Market Forecast Units	USD Billion
Key Companies Profiled	Coloplast, Teleflex, Stryker, Cook Medical, C.R. Bard, Medtronic, Karl Storz, Baxter, Johnson & Johnson, Olympus Corporation, Merit Medical Systems, Boston Scientific
Segments Covered	Product Type, End-user, Indication, Material, Regional
Key Market Opportunities	Rising prevalence of kidney disorders, Advancements in minimally invasive therapies, Increasing demand for renal stenting, Growing preference for home healthcare solutions, Expanding patient awareness and education
Key Market Dynamics	Rising prevalence of kidney diseases, Increasing adoption of minimally invasive procedures, Growing aging population, Technological advancements in treatment options, Expanding healthcare infrastructure in emerging markets
Countries Covered	North America, Europe, APAC, South America, MEA